Literature DB >> 34313857

Intensive oral care can reduce bloodstream infection with coagulase-negative staphylococci after neutrophil engraftment in allogeneic hematopoietic stem-cell transplantation.

Tatsuya Suwabe1, Kyoko Fuse2, Kouji Katsura3, Marie Soga3, Takayuki Katagiri1, Yasuhiko Shibasaki1, Miwako Narita4, Hirohito Sone1, Masayoshi Masuko5.   

Abstract

PURPOSE: Bloodstream infection (BSI) is a major complication of allogeneic hematopoietic stem-cell transplantation (allo-SCT). There are several causes of BSI; in particular, severe oral mucositis (OM) can induce BSI due to coagulase-negative staphylococci (CoNS). The OM severity may be reduced with intensive oral care. Thus, we evaluated whether the type of oral care affects the BSI incidence eventually.
METHOD: We performed retrospective analysis on 206 recipients who underwent allo-SCT from 2006 to 2017 at our institute. Intensive oral care by a dental specialist was performed for 111 recipients (intensive-care group) and self-oral care was performed by 95 recipients (self-care group). Incidence of BSI was assessed by type of the oral care, before neutrophil engraftment (pre-E-BSI) and after neutrophil engraftment (post-E-BSI) period until 180 days after allo-SCT. RESULT: A total of 112 BSI occurred in 90 of the 206 recipients and 120 bacteria were identified, with CoNS being the most prevalent. There was no significant difference in the incidence of pre-E-BSI between the self-care and intensive-care groups (30.8% and 30.6%, respectively; P = 0.508). Meanwhile, the incidence of post-E-BSI was significantly lower in the intensive-care group than in the self-care group (14.3% and 28.6%; P = 0.008). In addition, the intensive-care group had significantly lower incidence of post-E-BSI with CoNS than the self-care group (8.5% and 21.5%, respectively; P = 0.009).
CONCLUSION: Intensive oral care through the period of allo-HCT can significantly reduce the post-E-BSI occurrence, especially due to CoNS.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Blood stream infection; Hematopoietic stem-cell transplantation; Neutrophil engraftment; Oral care; Oral mucositis

Mesh:

Substances:

Year:  2021        PMID: 34313857     DOI: 10.1007/s00520-021-06447-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  22 in total

1.  Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.

Authors:  Jo-Anne H Young; Brent R Logan; Juan Wu; John R Wingard; Daniel J Weisdorf; Cathryn Mudrick; Kristin Knust; Mary M Horowitz; Dennis L Confer; Erik R Dubberke; Steven A Pergam; Francisco M Marty; Lynne M Strasfeld; Janice Wes M Brown; Amelia A Langston; Mindy G Schuster; Daniel R Kaul; Stanley I Martin; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

2.  Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.

Authors:  M Kikuchi; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; K Sakamoto; K Kawamura; Y Ishihara; M Sato; M Ashizawa; K Terasako-Saito; S Kimura; R Yamazaki; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Transpl Infect Dis       Date:  2015-01-12       Impact factor: 2.228

3.  Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.

Authors:  S Kurosawa; K Yakushijin; T Yamaguchi; Y Atsuta; T Nagamura-Inoue; H Akiyama; S Taniguchi; K Miyamura; S Takahashi; T Eto; H Ogawa; M Kurokawa; J Tanaka; K Kawa; K Kato; R Suzuki; Y Morishima; H Sakamaki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2012-09-10       Impact factor: 5.483

4.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

Authors:  Giampaolo Bucaneve; Alessandra Micozzi; Francesco Menichetti; Pietro Martino; M Stella Dionisi; Giovanni Martinelli; Bernardino Allione; Domenico D'Antonio; Maurizio Buelli; A Maria Nosari; Daniela Cilloni; Eliana Zuffa; Renato Cantaffa; Giorgina Specchia; Sergio Amadori; Francesco Fabbiano; Giorgio Lambertenghi Deliliers; Francesco Lauria; Robin Foà; Albano Del Favero
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

5.  Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.

Authors:  C-Y Liu; Y-C Lai; L-J Huang; Y-W Yang; T-L Chen; L-T Hsiao; J-H Liu; J-P Gau; P-M Chen; C-H Tzeng; T-J Chiou
Journal:  Bone Marrow Transplant       Date:  2010-11-29       Impact factor: 5.483

6.  Reduced mortality after allogeneic hematopoietic-cell transplantation.

Authors:  Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren A Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Journal:  N Engl J Med       Date:  2010-11-25       Impact factor: 91.245

7.  Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.

Authors:  N G Almyroudis; A Fuller; A Jakubowski; K Sepkowitz; D Jaffe; T N Small; T E Kiehn; E Pamer; G A Papanicolaou
Journal:  Transpl Infect Dis       Date:  2005-03       Impact factor: 2.228

Review 8.  The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.

Authors:  Hafsa M Chaudhry; Alison J Bruce; Robert C Wolf; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Walter K Kremers; Gordon L Phillips; Shahrukh K Hashmi
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-26       Impact factor: 5.742

9.  Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.

Authors:  S Kurosawa; K Yakushijin; T Yamaguchi; Y Atsuta; T Nagamura-Inoue; H Akiyama; S Taniguchi; K Miyamura; S Takahashi; T Eto; H Ogawa; M Kurokawa; J Tanaka; K Kawa; K Kato; R Suzuki; Y Morishima; H Sakamaki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2013-04-08       Impact factor: 5.483

10.  Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.

Authors:  O Blennow; P Ljungman; E Sparrelid; J Mattsson; M Remberger
Journal:  Transpl Infect Dis       Date:  2013-12-30       Impact factor: 2.228

View more
  1 in total

1.  Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Vladimíra Radochová; Martin Šembera; Radovan Slezák; Ondřej Heneberk; Jakub Radocha
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.